Graham Holdings
16
20M
15
0.21
5
0.06
3
- Areas of investment
Summary
Graham Holdings is the famous Corporate Investor, which was founded in 1947. The venture was found in North America in United States. The leading representative office of defined Corporate Investor is situated in the Arlington.
Among the most popular portfolio startups of the fund, we may highlight D2L, Intersection, Intersection. We can highlight the next thriving fund investment areas, such as Health Care, Software. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low.
Comparing to the other companies, this Graham Holdings performs on 7 percentage points less the average number of lead investments. Speaking about the real fund results, this Corporate Investor is 24 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2019. The important activity for fund was in 2014. The typical startup value when the investment from Graham Holdings is 10-50 millions dollars. Deals in the range of 50 - 100 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Graham Holdings, startups are often financed by New Enterprise Associates, SWaN & Legend Venture Partners, Revolution. The meaningful sponsors for the fund in investment in the same round are NewSpring Capital, ArrowMark Partners, The New York Times. In the next rounds fund is usually obtained by WPP, The Cedars-Sinai Accelerator, Techstars.
Investments analytics
Analytics
- Total investments
- 16
- Lead investments
- 5
- Exits
- 3
- Rounds per year
- 0.21
- Follow on index
- 0.06
- Investments by industry
- Media and Entertainment (5)
- Podcast (4)
- Advertising (4)
- Publishing (3)
- Apps (3) Show 39 more
- Investments by region
-
- United States (15)
- Canada (1)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 4M
- Group Appearance index
- 0.88
- Avg. company exit year
- 4
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
DUPLAYS | 01 May 2012 | Social, Fitness, Sports | Seed | 0 | United Arab Emirates, Dubai |
Edge Medical Robotics | 01 Apr 2020 | Health Care | Early Stage Venture | 0 | China, Guangdong Province, Futian District |
Flieber | 23 Oct 2019 | Supply Chain Management, Analytics, Information Technology, Retail Technology | Seed | 3M | United States, New York, New York |
Framebridge | 25 Apr 2019 | E-Commerce, Internet, Retail, Home Decor | Late Stage Venture | 15M | United States, Washington, District of Columbia |
Podsights | 23 Mar 2021 | Analytics, Advertising, Podcast | Seed | 4M | United States, New York, New York |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.